|
BGLC Bionexus Gene Lab Corp 1737523 |
| Income Statement |
|
Revenue
|
bglc_10q
|
2,630,376 |
|
Net Income
|
bglc_10q
|
-1,345,370 |
|
Profit Margin
|
|
-51.15% |
| Balance Sheet |
|
Current Assets
|
7,039,453 |
|
Assets
|
10,995,055 |
|
Current Liabilities
|
1,414,869 |
|
Liabilities
|
1,606,882 |
|
Equity
|
9,388,173 |
|
Shares Out
|
17,968,000 |
| Cash Flow Statement |
|
Operating Cash Flow
|
-2,164,489 |
|
Investing Cash Flow
|
-75,956 |
| Market Analysis |
Market Cap
|
7,745,862 |
|
Price
|
0.30 |
|
BVPS
|
0.52 |
|
PB
|
0.59 |
|
EPS
|
-0.11 |
|
PS
|
0.74 |
|
FCF
|
-2,240,445 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view BGLC documents filed with the SEC.
BGLC Filings
Clear
